A facial plastic surgeon reveals the MRI data on "Ozempic face," why repeated masseter Botox can thin the jawbone, and the topical rapamycin resetting skin cells to a 20-year-old phenotype.
In this episode of Health Longevity Secrets, Robert Lufkin MD sits down with Dr. Kay Durairaj, a USC and UCLA-trained facial plastic surgeon bringing evidence-based medicine to the longevity-aesthetics frontier. Old friends from their UCLA head and neck tumor-board days, they dig into the science most aesthetic clinics gloss over: how GLP-1 drugs uniquely strip facial fat, why exosomes and peptides are a "Wild West," the surprising data on retinoids and epigenetic aging, and how collagen biostimulators and topical rapamycin may genuinely rejuvenate skin at the cellular level.
Chapters:
00:00 — Introduction
02:03 — From Head & Neck Cancer Surgery to Longevity Aesthetics
03:04 — Bringing Evidence-Based Medicine to the Aesthetics Wild West
04:06 — Why Aging Should Be Treated as a Disease
06:07 — Ozempic Face: The MRI Data on Facial Fat Loss
09:14 — The Mid-Face Miracle Protocol: Collagen Biostimulators
10:15 — Reversing Ozempic Face After Rapid Weight Loss
11:15 — Exosomes Explained: Real Biology vs Marketing Hype
14:18 — How to Vet Exosome Sourcing, Purity and Shelf Life
16:22 — The Peptide Wild West: BPC-157, SS-31 and FDA-Approved Options
19:28 — N-of-1 Peptide Risks: Angiogenesis and Oncogenes
20:28 — Do Retinoids Accelerate Aging? The MitraBio Epigenetic Data
23:32 — Sculptra and Radiesse: Real Regenerative Science
25:33 — Masseter Botox and Permanent Jawbone Thinning
29:37 — Three Facial Biomarkers of Biological Age
31:38 — Does Lifting Weights Help or Hurt Your Face?
36:48 — Topical Rapamycin: Resetting Fibroblasts to a 20-Year-Old
40:51 — A New Peptide Skin-Longevity Line and Final Advice
Key takeaways:
GLP-1 drugs uniquely attack facial fat — MRI data show roughly 7% midfacial volume loss for every 10 kg of weight lost, primarily from superficial and deep cheek fat pads, driving "Ozempic face."
Collagen biostimulators (like Sculptra and Radiesse) can preserve or restore facial volume during rapid weight loss and have 20+ years and 200+ peer-reviewed papers behind their collagen-remodeling effects.
The exosome and research-peptide markets are largely unregulated — source, purity, shelf life, and donor quality matter, and lyophilized "exosome" skincare is often just protein fragments.
Repeated masseter Botox can thin the mandibular bone, especially in postmenopausal women — animal data are consistent, human data are mixed, so caution is warranted with aggressive long-term use.
Topical rapamycin (a "rapalog") may reset the fibroblast mTOR cycle, shifting aged, bloated skin cells toward a younger, spindle-shaped phenotype — an emerging frontier in cellular skin rejuvenation.
⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you!
New episodes every other Tuesday. Subscribe so you don't miss one.
Continue this conversation on Substack: https://robertlufkinmd.substack.com
Podden och tillhörande omslagsbild på den här sidan tillhör
Robert Lufkin MD. Innehållet i podden är skapat av Robert Lufkin MD och inte av,
eller tillsammans med, Poddtoppen.
